Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 788

The DOI matches its Crossref record.

BIPHASIC DEVELOPMENT OF CARRAGEENIN EDEMA IN RATS

VINEGAR, R., SCHREIBER, W., HUGO, R.·1969·The Journal of Pharmacology and Experimental Therapeutics

Abstract

Accumulation of edema fluid as a function of time after the subplantar injection of 0.50 mg of carrageenin in rats is biphasic. The first phase begins immediately after injection of the irritant and diminishes in an hour. The second period of accelerated edema formation begins at the end of the 1st hr and persists through the 3rd hr. The first phase accounts for approximately 40% of the total edema volume produced in 3 hr. Foot skin temperature measurements taken after the subplantar administration of carrageenin gave a biphasic increase with time. Peak temperatures coincided with the two periods of rapid edema development and the trough with the interperiod. Hydrocortisone did not inhibit development of the first phase of edema but was a potent inhibitor of the second. Acetylsalicylic acid was active against both phases. Phenylbutazone produced slight inhibition of the first phase, which was not dose-dependent, but strongly inhibited the second phase. Each of these standard antiinflammatory drugs produced more than 75% inhibition of the second phase at the highest dose used. A brief period of complete suppression was recorded for hydrocortisone and phenylbutazone. Indomethacin induced strong dose-dependent inhibition of the second phase at doses which did not affect the development of the first phase. When carrageenin was charred by heat treatment at 130°C for 16 hr, it elicited the full first phase edema volume without subsequent development of the second phase. This indicates that the second phase is not a consequence of processes initiated during the first phase but is dependent on the structural integrity of the irritant molecule.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0022-3565(25)28209-x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 788

Metadata

Authors
VINEGAR, R., SCHREIBER, W., & HUGO, R.
Venue
The Journal of Pharmacology and Experimental Therapeutics
Publisher
Elsevier BV
Published
1969-03
Volume
166
Issue
1
Pages
96-103
ISSN
0022-3565 (ISSN-L)
OpenAlex
W2261454648
Cited by
788
References
0
FWCI
2.80
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: BIPHASIC DEVELOPMENT OF CARRAGEENIN EDEMA IN RATS. https://app.cochat.ai/papers/10.1016/s0022-3565(25)28209-x
The paper
VINEGAR, R., SCHREIBER, W., & HUGO, R. (1969). BIPHASIC DEVELOPMENT OF CARRAGEENIN EDEMA IN RATS. The Journal of Pharmacology and Experimental Therapeutics. https://doi.org/10.1016/s0022-3565(25)28209-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.